01 August 2008
Mycoplasma pneumoniae pneumonia in the elderly
Naoyuki MiyashitaABCDEFG, Kazunobu OuchiEFG, Kozo KawasakiCDF, Keiko OdaCDF, Yasuhiro KawaiCDF, Hiroki ShimizuBCD, Yoshihiro KobashiBCD, Mikio OkaEFGMed Sci Monit 2008; 14(8): CR387-391 :: ID: 865773
Abstract
Background
Mycoplasma pneumoniae is one of the most common causes of community-acquired pneumonia (CAP). This infection occurs predominantly in school-aged children and younger adults, but may also occur in the elderly.
Material and Method
To investigate the frequency and clinical characteristics of M. pneumoniae pneumonia in the elderly, we analyzed 210 hospitalized patients with M. pneumoniae pneumonia over a 15-year period.
Results
Thirty-two (15.2%) were 60 years of age or older. The frequencies of a comorbid illness with the age >or=60-years group were significantly higher than those of the age <60-years group (p<0.0001). The symptoms were almost identical in both age groups, but the fever magnitude was significantly lower in the age >or=60-years group than the age <60-years group (p<0.0001). One or more additional etiological factors were found more frequently in the age >or=60-years group than in the age <60-years group (37.5% vs 10.1%, p=0.0003). The diagnostic sensitivity for M. pneumoniae pneumonia using the Japanese CAP guidelines scoring system was significantly lower in the age >or=60-years group than in the age <60-years group (50% vs 90%, p <0.0001).
Conclusions
Our results indicate that the frequency of M. pneumoniae pneumonia in the elderly was low but not rare. The symptoms and severity of the illness from this infection were almost identical in both age groups and the mortality rate was low even in the elderly. It seems to be difficult to distinguish between M. pneumoniae pneumonia and bacterial pneumonia in the elderly.
Keywords: Pneumonia, Mycoplasma - microbiology, Japan - epidemiology, Mycoplasma pneumoniae - physiology, Community-Acquired Infections - microbiology, Age Distribution
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952